Literature DB >> 3927073

Suppression of the alveolitis in pulmonary sarcoidosis by oral corticosteroids.

G A Rossi, G B Di Negro, E Balzano, E Cerri, O Sacco, B Balbi, A Venturini, R Ramoino, C Ravazzoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3927073     DOI： 10.1007/bf02713810

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  31 in total

1.  Course and prognosis of sarcoidosis: London.

Authors:  D G JAMES
Journal:  Am Rev Respir Dis       Date:  1961-11

2.  Sarcoidosis and mononuclear phagocytes.

Authors:  J B Gee; P T Bodel; S K Zorn; L M Hinman; C A Stevens; R A Matthay
Journal:  Lung       Date:  1978       Impact factor: 2.584

3.  Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?

Authors:  B A Keogh; R G Crystal
Journal:  Chest       Date:  1980-12       Impact factor: 9.410

4.  Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas.

Authors:  Y Rosen; T J Athanassiades; S Moon; H A Lyons
Journal:  Chest       Date:  1978-08       Impact factor: 9.410

5.  Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.

Authors:  G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

6.  Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.

Authors:  G W Hunninghake; J E Gadek; R C Young; O Kawanami; V J Ferrans; R G Crystal
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

7.  Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis.

Authors:  G W Hunninghake; G N Bedell; D C Zavala; M Monick; M Brady
Journal:  Am Rev Respir Dis       Date:  1983-10

8.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

Authors:  S I Rennard; G W Hunninghake; P B Bitterman; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

10.  Glucocorticoid suppression of macrophage migration inhibitory factor.

Authors:  J E Balow; A S Rosenthal
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307
View more
  1 in total

1.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.